Clinical Trials Browser

Phase 2 × FED × Small Cell Lung Carcinoma × Clear all

NCT01417806 2011-08-16

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma